Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Johnston to replace Stolze as Stereotaxis CFO

This article was originally published in Clinica

Executive Summary

Stereotaxis, developer of computer-controlled catheters and guidewires used in cardiovascular surgery, has appointed Daniel Johnson successor to its retiring chief financial officer James Stolze. Mr Johnson, who is currently executive vice-president and CFO of automobile parts manufacturer United Components, will join St Louis, Missouri-based Stereotaxis in September, and officially assume his new position on November 15. He brings to the company over 15 years' senior financial management experience. Mr Stolze will retire at the end of 2009, but will remain as consultant to Stereotaxis until June 2011.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT044000

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel